Eisai Expects Alzheimer’s Drug Leqembi Sales to Grow to $900 Million in 2026, Thanks to Innovations in Diagnosis and Treatment Delivery
Eisai, the company that makes the Alzheimer’s drug Leqembi, expects its sales to nearly double next year, reaching about $900 […]